Literature DB >> 29995175

Nitric Oxide Participates in the Brain Ischemic Tolerance Induced by Intermittent Hypobaric Hypoxia in the Hippocampal CA1 Subfield in Rats.

Ya-Jie Huang1, Yu-Jia Yuan1, Yi-Xian Liu2, Meng-Yue Zhang1, Jing-Ge Zhang3, Tian-Ci Wang1, Li-Nan Zhang4, Yu-Yan Hu4, Li Li5, Xiao-Hui Xian4, Jie Qi4, Min Zhang6,7.   

Abstract

Previous studies have shown that intermittent hypobaric hypoxia (IH) preconditioning protected neurons survival from brain ischemia. However, the mechanism remains to be elucidated. The present study explored the role of nitric oxide (NO) in the process by measuring the expression of NO synthase (NOS) and NO levels. Male Wistar rats (100) were randomly assigned into four groups: sham group, IH + sham group, ischemia group and IH + ischemia group. Rats for IH preconditioning were exposed to hypobaric hypoxia mimicking 5000 m high-altitude (PB = 404 mmHg, PO2 = 84 mmHg) 6 h/day, once daily for 28 days. Global brain ischemia was established by four-vessel occlusion that has been created by Pulsinelli. Rats were sacrificed at 7th day after the ischemia for neuropathological evaluation by thionin stain. In addition, the expression of neuronal NOS (nNOS), inducible NOS (iNOS), and NO content in the hippocampal CA1 subfield were measured at 2nd day and 7th day after the ischemia. Results revealed that global brain ischemia engendered delayed neuronal death (DND), both nNOS and iNOS expression up-regulated, and NO content increased in the hippocampal CA1 subfield. IH preconditioning reduced neuronal injury induced by the ischemia, and prevented the up-regulation of NOS expression and NO production. In addition, L-NAME + ischemia group was designed to detect whether depressing NO production could alleviate the DND. Pre-administration of L-NAME alleviated DND induced by the ischemia. These results suggest that IH preconditioning plays a protective role by inhibiting the over expression of NOS and NO content after brain ischemia.

Entities:  

Keywords:  Global brain ischemia; Hippocampal CA1 subfield; Intermittent hypobaric hypoxia; Nitric oxide; Nitric oxide synthase

Mesh:

Substances:

Year:  2018        PMID: 29995175     DOI: 10.1007/s11064-018-2593-9

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  51 in total

1.  Delayed neural damage is induced by iNOS-expressing microglia in a brain injury model.

Authors:  Kenji Ono; Hiromi Suzuki; Makoto Sawada
Journal:  Neurosci Lett       Date:  2010-02-21       Impact factor: 3.046

2.  Tests of the roles of two diffusible substances in long-term potentiation: evidence for nitric oxide as a possible early retrograde messenger.

Authors:  T J O'Dell; R D Hawkins; E R Kandel; O Arancio
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

3.  A new model of bilateral hemispheric ischemia in the unanesthetized rat.

Authors:  W A Pulsinelli; J B Brierley
Journal:  Stroke       Date:  1979 May-Jun       Impact factor: 7.914

4.  Aberrant expression of nNOS in pyramidal neurons in Alzheimer's disease is highly co-localized with p21ras and p16INK4a.

Authors:  H J Lüth; M Holzer; H J Gertz; T Arendt
Journal:  Brain Res       Date:  2000-01-03       Impact factor: 3.252

5.  Nitric oxide participates in the induction of brain ischemic tolerance via activating ERK1/2 signaling pathways.

Authors:  Hui-Qing Liu; Wen-Bin Li; Qing-Jun Li; Min Zhang; Xiao-Cai Sun; Rong-Fang Feng; Xiao-Hui Xian; Shu-Qin Li; Jie Qi; Hong-Gang Zhao
Journal:  Neurochem Res       Date:  2006-07-18       Impact factor: 3.996

6.  Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase.

Authors:  Z Huang; P L Huang; N Panahian; T Dalkara; M C Fishman; M A Moskowitz
Journal:  Science       Date:  1994-09-23       Impact factor: 47.728

7.  Single nucleotide polymorphisms (SNPs) for genome wide association studies (GWAS) and molecule of the month Nitric Oxide Synthase, multiple interactive pathways for three similar genes, Nitric Oxide Synthase-1, -2, -3 (NOS-1, -2, -3).

Authors:  Paul Shapshak
Journal:  Bioinformation       Date:  2012-06-16

8.  Hypertonic saline attenuates expression of Notch signaling and proinflammatory mediators in activated microglia in experimentally induced cerebral ischemia and hypoxic BV-2 microglia.

Authors:  Wen-Xin Zeng; Yong-Li Han; Gao-Feng Zhu; Lin-Qiang Huang; Yi-Yu Deng; Qiao-Sheng Wang; Wen-Qiang Jiang; Miao-Yun Wen; Qian-Peng Han; Di Xie; Hong-Ke Zeng
Journal:  BMC Neurosci       Date:  2017-03-14       Impact factor: 3.288

9.  Immediate Remote Ischemic Postconditioning Reduces Brain Nitrotyrosine Formation in a Piglet Asphyxia Model.

Authors:  Eridan Rocha-Ferreira; Brogan Rudge; Michael P Hughes; Ahad A Rahim; Mariya Hristova; Nicola J Robertson
Journal:  Oxid Med Cell Longev       Date:  2016-06-09       Impact factor: 6.543

Review 10.  Role of Homocysteine in the Ischemic Stroke and Development of Ischemic Tolerance.

Authors:  Ján Lehotský; Barbara Tothová; Maria Kovalská; Dušan Dobrota; Anna Beňová; Dagmar Kalenská; Peter Kaplán
Journal:  Front Neurosci       Date:  2016-11-23       Impact factor: 4.677

View more
  3 in total

1.  Neuroprotective effect of intermittent hypobaric hypoxia preconditioning on cerebral ischemia/reperfusion in rats.

Authors:  Wu Yue; Gu Cunlin; Huang Lu; Zhao Yuanqing; Tang Yanjun; Wu Qiong
Journal:  Int J Clin Exp Pathol       Date:  2020-11-01

2.  eNOS-dependent S-nitrosylation of the NF-κB subunit p65 has neuroprotective effects.

Authors:  Ariel Caviedes; Barbara Maturana; Katherina Corvalán; Alexander Engler; Felipe Gordillo; Manuel Varas-Godoy; Karl-Heinz Smalla; Luis Federico Batiz; Carlos Lafourcade; Thilo Kaehne; Ursula Wyneken
Journal:  Cell Death Dis       Date:  2021-01-04       Impact factor: 8.469

3.  miR-92b-3p Exerts Neuroprotective Effects on Ischemia/Reperfusion-Induced Cerebral Injury via Targeting NOX4 in a Rat Model.

Authors:  Yongpan Huang; Jiayu Tang; Xiaojuan Li; Xian Long; Yansong Huang; Xi Zhang
Journal:  Oxid Med Cell Longev       Date:  2022-03-30       Impact factor: 6.543

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.